Arqule Inc. buy melinda
Start price
04.05.17
/
50%
€0.90
Target price
10.05.17
€0.99
Performance (%)
-3.51%
End price
10.05.17
€0.87
Summary
This prediction ended on 10.05.17 with a price of €0.87. With a performance of -3.51%, the BUY prediction for Arqule Inc. by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arqule Inc. | - | - | - | - |
| iShares Core DAX® | -2.023% | -3.140% | 10.499% | 13.078% |
| iShares Nasdaq 100 | 4.625% | 8.753% | 34.939% | 57.906% |
| iShares Nikkei 225® | -2.088% | -0.980% | 3.292% | 2.524% |
| iShares S&P 500 | 2.398% | 4.677% | 27.998% | 49.604% |
Comments by melinda for this prediction
In the thread Arqule Inc. diskutieren
intrahepatischen cholangiocarcinoma
hat Einschreibung von Phase 2. Diskussion Post at ASCO am 3. abgeschlossen Juni 2017. Phase 3 für das 3. Quartal 2017 geplant.